12,062 Shares in Option Care Health, Inc. (NASDAQ:OPCH) Acquired by Squarepoint Ops LLC

Squarepoint Ops LLC acquired a new position in Option Care Health, Inc. (NASDAQ:OPCH - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund acquired 12,062 shares of the company's stock, valued at approximately $280,000.

A number of other large investors have also made changes to their positions in the business. Cornerstone Investment Partners LLC grew its holdings in shares of Option Care Health by 3.6% during the fourth quarter. Cornerstone Investment Partners LLC now owns 9,544 shares of the company's stock valued at $221,000 after buying an additional 333 shares during the last quarter. Assetmark Inc. boosted its holdings in Option Care Health by 2.0% in the fourth quarter. Assetmark Inc. now owns 24,976 shares of the company's stock valued at $579,000 after purchasing an additional 487 shares during the last quarter. Blue Trust Inc. boosted its holdings in Option Care Health by 16.9% in the fourth quarter. Blue Trust Inc. now owns 4,703 shares of the company's stock valued at $109,000 after purchasing an additional 681 shares during the last quarter. Xponance Inc. boosted its holdings in Option Care Health by 3.9% in the fourth quarter. Xponance Inc. now owns 25,056 shares of the company's stock valued at $581,000 after purchasing an additional 944 shares during the last quarter. Finally, Signaturefd LLC boosted its holdings in Option Care Health by 487.9% in the fourth quarter. Signaturefd LLC now owns 1,211 shares of the company's stock valued at $28,000 after purchasing an additional 1,005 shares during the last quarter. 98.05% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of research analysts have weighed in on the stock. JMP Securities reiterated a "market outperform" rating and issued a $36.00 price objective on shares of Option Care Health in a research report on Tuesday, April 22nd. Barrington Research restated an "outperform" rating and set a $38.00 price target on shares of Option Care Health in a research report on Wednesday, April 30th. JPMorgan Chase & Co. upped their price target on shares of Option Care Health from $40.00 to $41.00 and gave the stock an "overweight" rating in a research report on Thursday, March 6th. Finally, UBS Group upgraded shares of Option Care Health from a "neutral" rating to a "buy" rating and upped their price target for the stock from $38.00 to $40.00 in a research report on Wednesday, April 30th. One equities research analyst has rated the stock with a hold rating and seven have given a buy rating to the company's stock. According to data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and an average target price of $35.50.

Option Care Health Stock Performance

NASDAQ OPCH opened at $31.90 on Friday. The company has a quick ratio of 1.32, a current ratio of 1.73 and a debt-to-equity ratio of 0.77. Option Care Health, Inc. has a 52-week low of $21.39 and a 52-week high of $35.53. The business's 50-day moving average price is $32.42 and its 200 day moving average price is $29.95. The firm has a market cap of $5.22 billion, a P/E ratio of 26.81, a P/E/G ratio of 2.30 and a beta of 0.74.

Option Care Health (NASDAQ:OPCH - Get Free Report) last announced its quarterly earnings results on Tuesday, April 29th. The company reported $0.40 EPS for the quarter, topping the consensus estimate of $0.36 by $0.04. Option Care Health had a return on equity of 15.30% and a net margin of 4.37%. The business had revenue of $1.33 billion for the quarter, compared to analyst estimates of $1.26 billion. During the same quarter in the previous year, the company earned $0.26 EPS. The company's quarterly revenue was up 16.3% on a year-over-year basis. On average, equities research analysts expect that Option Care Health, Inc. will post 1.22 earnings per share for the current year.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.